Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New blood score could predict septic shock survival

NCT ID NCT01231672

Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new scoring system that uses routine blood tests to predict the risk of death within one month for patients in intensive care with septic shock. Researchers looked at 780 patients to see how well the score works. The goal is to help doctors make faster, better decisions for these very sick patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

780 people

The number who actually took part.

Start date

Apr 2009

Finished

Oct 2013

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Severe septic shock patients entering intensive care units in the participating centers.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * patient (or representative) received the information notice * patient has hemodynamic insufficiency of non-traumatic or cardiogenic origin associated with severe sepsis (treated with Noradrenalin) and organ dysfunction, hypoperfusion or hypotension * body temperature \> 38.3°C or \< 36°C * heart rate \> 90 bpm * Tachypnea \> 20 C/min or PaCO2 \< 32 mmHg or mechanical ventilation * leukocytes \> 12000 µL-1 ou \< 4000 µL-1 ou \> 10% immature forms * oliguria \< 0.5 ml/kg/h for at least 2 hours * abrupt alteration (24 h) of conscienceness * thrombocytopenia \< 100 000 G/L or disseminated intravascular coagulation * mottled skin and / or capillary refill time\> 3 sec * PaO2/FiO2 \< 300 mmHg ou \< 40KPas * Lactatemia \> 2mMol/l * septic shock: Systolic Blood Pressure (SBP) \> 90 mmHg or need for vasopressors to maintain SBP\> 90 mmHg despite a prior filling (20-30 ml / kg of macromolecules or 40 to 60 ml / kg of normal saline (or decrease in SBP\> 40% in the hypertensive) Exclusion Criteria: * patient is dying or limitation or cessation of active treatment * patient is already included in another trial * patient or family refusal * patient not affiliated with a social security system

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Shock, septic are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

toxic shock syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Shock, septic

Contacts and locations

Locations

  • AP-HM Hôpital Nord

    Marseille, 13915, France

  • APHM - Hôpital de la Conception

    Marseille, 13385, France

  • CHU de Clermont Ferrand - Hôpital Estaing

    Clermont-Ferrand, 63003, France

  • CHU de Nice

    Nice, France

  • CHU de Saint Etienne

    Saint-Etienne, 42055, France

  • Centre Hospitalier Universitaire de Montpellier

    Montpellier, France

  • Centre Hospitalier Universitaire de Nîmes

    Nîmes, 30029, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.